BioMarin Pharmaceutical Inc.
Biotechnology • Pharmaceuticals
BioMarin Pharmaceutical Inc. is a leading global biotechnology company dedicated to transforming genetic discoveries into innovative medicines. Founded in 1997, the company has developed eight marketed products that address life-threatening genetic and lysosomal storage disorders such as achondroplasia and severe hemophilia A. BioMarin is also heavily invested in research and development, with a robust pipeline of investigational medicines at various clinical trial stages. The company's mission revolves around improving patient care by leveraging scientific expertise to understand the underlying causes of these conditions. BioMarin is committed to inclusivity and patient advocacy, engaging closely with communities to enhance care and quality of life for those with rare conditions.
1001 - 5000 employees
Founded 1997
🧬 Biotechnology
đź’Š Pharmaceuticals
đź’° Post-IPO Debt on 2020-05
Director, Global Medical Engagement - Phenylketonuria (PKU) / Lysosomal Storage Disorders (LSDs)
June 5
BioMarin Pharmaceutical Inc.
Biotechnology • Pharmaceuticals
BioMarin Pharmaceutical Inc. is a leading global biotechnology company dedicated to transforming genetic discoveries into innovative medicines. Founded in 1997, the company has developed eight marketed products that address life-threatening genetic and lysosomal storage disorders such as achondroplasia and severe hemophilia A. BioMarin is also heavily invested in research and development, with a robust pipeline of investigational medicines at various clinical trial stages. The company's mission revolves around improving patient care by leveraging scientific expertise to understand the underlying causes of these conditions. BioMarin is committed to inclusivity and patient advocacy, engaging closely with communities to enhance care and quality of life for those with rare conditions.
1001 - 5000 employees
Founded 1997
🧬 Biotechnology
đź’Š Pharmaceuticals
đź’° Post-IPO Debt on 2020-05
đź“‹ Description
• Lead development of the global medical engagement strategy for PKU/LSDs aligning with the medical plan • Collaboration with the Medical Engagement Medical Excellence (MEMX) lead • Development of the external medical expert engagement plan • Accountable for execution of the medical engagement strategy among prioritized countries • Lead development of engagement strategy as it relates to key messages from clinical trial results • Strong collaborations with the Global Medical Engagement lead for Skeletal Conditions
🎯 Requirements
• Advanced life science degree (e.g. doctoral degree, master’s level degree) and at least 4 years relevant industry experience required • PKU/LSD knowledge/experience ideal • 4 or more years of relevant experience in clinical science, medical affairs, and/or drug development desired • Successful people leadership experience desired, ideally of field-based team members
Apply NowSimilar Jobs
June 5
Develop and manage fundraising strategies for ALS Association events while leading a team.
June 3
Abnormal Security
501 - 1000
🇺🇸 United States – Remote
đź’µ $212.5k - $250k / year
⏰ Full Time
đź”´ Lead
đź‘” Director
🦅 H1B Visa Sponsor
June 3
Direct IT strategy and cybersecurity efforts for Marmon Holdings’ Heavy-Duty Components platform, ensuring alignment with corporate goals.
June 2
Direct IT operations and ERP harmonization at Marmon Holdings. Oversee technology strategy and team leadership.
June 1
Drive continuous improvement as a Director at Watts, specializing in Lean methodologies for manufacturing sites.
🇺🇸 United States – Remote
đź’µ $140k - $180k / year
⏰ Full Time
đź”´ Lead
đź‘” Director
🦅 H1B Visa Sponsor